Completed
Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones
NCT00576589
- Conditions
- Biliary Tract Diseases, Body Weight, Calculi, +13 more
- Locations
-
- Pfizer Investigational Site Anniston, Alabama, United States
- Pfizer Investigational Site Anniston, Alabama, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Anaheim, California, United States